trending Market Intelligence /marketintelligence/en/news-insights/trending/krm1lzumplqtzgtu1o6n7q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Marinus adds former Pacira Pharmaceuticals COO to board

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Marinus adds former Pacira Pharmaceuticals COO to board

Marinus Pharmaceuticals Inc. appointed Scott Braunstein to its board.

Braunstein currently serves as an operating partner at Aisling Capital Management LP, a New York-based venture capital and private equity firm.

Prior to joining Aisling, Braunstein was the COO of Pacira Pharmaceuticals Inc., a Parsippany, N.J.-based specialty pharmaceutical company that develops and manufactures products for acute care practitioners and their patients.

Radnor, Pa.-based Marinus Pharmaceuticals is focused on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders.